Nicox Email Format
Pharmaceutical ManufacturingProvence-alpes-côte D'azur, France11-50 Employees
Nicox is an international ophthalmic research and development company based in Sophia Antipolis, in the Provence-Alpes-Côte d'Azur region of France, focused on pharmaceutical manufacturing. It aims to assemble a diversified portfolio of eye-care therapies to meet the needs of eyecare practitioners and patients worldwide. The firm pursues growth through international collaborations and through proprietary programs, including those from its nitric oxide-donating research platform. Its lead candidate, NCX 470, is being developed in Phase 3 trials. In September 2024, Nicox announced an exclusive research and license option with Glaukos for NCX 1728, supporting preclinical research in glaucoma and other retinal diseases.